Tag: Oncology

Engineered Matrix to Improve T Cell Immunotherapy

Researchers from Johns Hopkins University have developed an “artificial lymph node” to help multiply antigen-specific T cells to fight cancer. They used a hydrogel that contains immunostimulatory antigen-presenting nanoparticles to encourage T cells to proliferate, and have increased activity against specific antigens. Current T-cell ba (Read more...)

Wearable Device Samples User’s Blood to Spot Cancer Cells

Circulating tumor cells (CTCs) cause metastases of cancer, but they might have a redeeming quality if we could use them as biomarkers for those very cancers. For most neoplasms, biopsies are performed to definitively diagnose the disease, but circulating tumor cells offer the possibility of “liquid biopsies” that only require the sampli (Read more...)

Wearable Device Samples User’s Blood to Spot Cancer Cells

Circulating tumor cells (CTCs) cause metastases of cancer, but they might have a redeeming quality if we could use them as biomarkers for those very cancers. For most neoplasms, biopsies are performed to definitively diagnose the disease, but circulating tumor cells offer the possibility of “liquid biopsies” that only require the sampli (Read more...)

Wearable Device Samples User’s Blood to Spot Cancer Cells

Circulating tumor cells (CTCs) cause metastases of cancer, but they might have a redeeming quality if we could use them as biomarkers for those very cancers. For most neoplasms, biopsies are performed to definitively diagnose the disease, but circulating tumor cells offer the possibility of “liquid biopsies” that only require the sampli (Read more...)

Bioengineered Gel to Reduce Risk of Bone Marrow Transplants

Bone marrow transplantation is a potentially life-saving treatment for leukemia, multiple myeloma, and HIV. The procedure involves depleting the patient’s immune system, then infusing blood stem cells from a donor, which develop into a new immune system. Unfortunately, during the transplant process, patients are susceptible to disease and inf (Read more...)

Fenwal Amicus Red Blood Cell Exchange System

Fresenius Kabi, a company based in Bad Homburg, Germany, announced that its Fenwal Amicus Red Blood Cell Exchange (RBCx) system won clearance from the FDA. The device can automatically remove patient’s blood cells and replace them with another fluid, particularly useful when treating sickle cell disease. The system can perform exchange, (Read more...)

Blood Test for Early Stage Cancer Diagnosis: Interview with Dr. Van Etten, CMO of Laboratory for Advanced Medicine

The Laboratory for Advanced Medicine (LAM), a biotechnology company headquartered in the US, offers non-invasive, early stage cancer detection tests that will use the IvyGene Platform. These IvyGene tests are based on detecting genomic DNA shed by cancer cells into the blood stream. By assessing cell-free DNA found in blood samples, the company can (Read more...)

Philips HealthWorks Supports Startups Using AI for Radiology, Ultrasound, and Oncology: Interview

In Philips innovation hubs located in Cambridge, Massachusetts, Eindhover, Netherlands, Bangalore, India, and Shanghai, China, 19 startups out of 750 applicants are taking part in an intensive, 12-week Philips HealthWorks program to accelerate their innovations. The focus of this program is leveraging artificial intelligence (AI) in healthcare with (Read more...)